Bay City Capital is a life sciences venture capital firm that invests in opportunities across the various life sciences sectors in companies at all stages of development. Established in 1997, the firm has managed eight venture capital funds representing over $1.6 billion in capital commitments. Bay City Capital has invested in over 100 life sciences companies globally, including Civitas, Dermira, Epizyme, Epocrates, Hyperion Therapeutics, Idev Technologies, Ion Torrent Systems, MAP Pharmaceuticals, Medarex, Nabsys, NextWave Pharmaceuticals, Oculex Pharmaceuticals, Pharmion, Reliant Pharmaceuticals, and Sunesis Pharmaceuticals.
View Top Employees from Bay City Capital| Website | http://www.baycitycapital.com |
| Revenue | $24 million |
| Employees | 23 (23 on RocketReach) |
| Founded | 1997 |
| Address | 750 Battery St, Ste 400, San Francisco, California 94111, US |
| Phone | (415) 676-3830 |
| Fax | (415) 837-0503 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+16 more
(view full list)
|
| Category | Biotechnology, Venture Capital & Private Equity, Finance, Science and Engineering |
| Web Rank | 6 Million |
| Keywords | bay city capital, david beier, baycity capital, bay city capital gf xinde, bay city capital fund ii co-invest. fund, lp |
| Competitors | 5AM Ventures, Alta Partners, Domain Associates, HealthCare Ventures LLC, Pappas Capital |
| SIC | 67, 679 |
| NAICS | 523, 5239, 52 |
Looking for a particular Bay City Capital employee's phone or email?
Bay City Capital Questions
The Bay City Capital annual revenue was $24 million in 2023.
Matt Kronmiller is the Vice President of Bay City Capital.
23 people are employed at Bay City Capital.
Bay City Capital is based in San Francisco, California.
The NAICS codes for Bay City Capital are [523, 5239, 52].
The SIC codes for Bay City Capital are [67, 679].
Top Bay City Capital Employees
-
22
-
14
-
35+
-
25+
-
25+
-
35+
-
11
Related Companies
